GCMRX
Price
$35.77
Change
+$0.31 (+0.87%)
Updated
Nov 24 closing price
Net Assets
1.07B
VIMAX
Price
$351.76
Change
+$2.06 (+0.59%)
Updated
Nov 24 closing price
Net Assets
198.55B
Interact to see
Advertisement

GCMRX vs VIMAX

Header iconGCMRX vs VIMAX Comparison
Open Charts GCMRX vs VIMAXBanner chart's image
Goldman Sachs Mid Cap Value R
Price$35.77
Change+$0.31 (+0.87%)
VolumeN/A
Net Assets1.07B
Vanguard Mid Cap Index Admiral
Price$351.76
Change+$2.06 (+0.59%)
VolumeN/A
Net Assets198.55B
GCMRX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
GCMRX vs. VIMAX commentary
Nov 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCMRX is a Buy and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 199B vs. GCMRX (1.07B). VIMAX pays higher dividends than GCMRX: VIMAX (1.49) vs GCMRX (0.48). GCMRX was incepted earlier than VIMAX: GCMRX (17 years) vs VIMAX (24 years). GCMRX (1.45) is less costly to investors than VIMAX (0.05). GCMRX is a more actively managed with annual turnover of: 56.00 vs. VIMAX (16.00). GCMRX has a lower initial minimum investment than VIMAX: GCMRX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 0.32 vs. GCMRX (-8.41). VIMAX return over 5 years is better than : 42.80 vs. GCMRX (4.27).
GCMRXVIMAXGCMRX / VIMAX
Total Expense Ratio1.440.052,880%
Annual Report Gross Expense Ratio1.450.052,900%
Fund Existence17 years24 years-
Gain YTD4.5097.08364%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B199B1%
Annual Yield % from dividends0.481.4932%
Returns for 1 year-8.410.32-2,630%
Returns for 3 years-1.0232.96-3%
Returns for 5 years4.2742.8010%
Returns for 10 years-4.01131.64-3%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATAT37.830.74
+2.00%
Atour Lifestyle Holdings Limited
CDNS304.473.89
+1.29%
Cadence Design Systems
CCCC2.460.02
+0.82%
C4 Therapeutics
AMC2.20N/A
N/A
AMC Entertainment Holdings
RNXT0.78-0.02
-1.95%
RenovoRx